New CPAP Mask Makes its U.S. Debut

ResMed is expanding its sleep apnea device offering in the United States, having launched the AirFit F40 mask.

The company touts the AirFit F40 as an ultra-compact, full-face mask that provides the comfort of smaller masks without sacrificing performance to help improve sleep apnea therapy compliance.²  ResMed claims 96% of patients using the AirFit F40 report having the freedom to sleep in their preferred position and change positions through the night.¹

“Most users prefer smaller and more streamlined masks, but traditional under-the-nose full-face masks can be challenging to fit properly, maintain a seal, and handle higher pressures. Our new AirFit F40 addresses this problem by offering the best of both worlds: an ultra-compact full-face mask with the high seal performance of an over-the-nose mask—bridging the gap between compactness and effectiveness in full-face masks,” ResMed Chief Product Officer Justin Leong said. 
 
Finding the right mask with the right fit and comfort can be daunting, especially for individuals requiring high-pressure CPAP treatment. The AirFit F40 addresses this problem by providing pressure support in a more comfortable, lower-profile full-face mask. According to ResMed, the mask is ideal for side sleepers, those who are claustrophobic, and people favoring a minimalist design. In a ResMed clinical study, 88% of patients rated AirFit F40’s mask cushion as soft and comfortable and 100% found AirFit F40 easy to use.³
 
A key AirFit F40 feature is the AdaptiSeal cushion, a 100% soft silicone cushion designed to maintain a facial seal, even when moving around during sleep. Additional features include:

• A fully flexible frame that keeps the assembly away from patients’ eyes and ears.
• A full-face mask with a quick-release short tube, reducing tube drag and offering a convenient way to detach and reattach the mask to the device during the night.
• Headgear without top strap adjustment, which makes for an easier setup and adjustment process.
• A new textile material and a dark grey color, offering a more modern look. 

ResMed next plans to release the AirFit F40 masks in Canada, then in EMEA (Europe, Middle East, Africa), Latin America, and APAC (Asia-Pacific). 

ResMed’s digital health technologies and cloud-connected medical devices aim to improve care for people with sleep apnea, COPD, and other chronic diseases. The firm’s out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. 

References 
^1,3 ResMed external clinical studies of current PAP users with ≥ 12 months’ therapy with either ResMed or competitor masks and who met 90-day compliance in the three months prior to the study. All participants used the ResMed AirFitF40 and a competitor mask for up to seven nights each at randomized order. Studies conducted in the U.S., October 4 -November 20, 2023. n=57.
² Compliance is defined by the CMS as certain number of hours per night, and number of nights of use within first 90 days.